Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0)
# 4286
Out of 5,298 analysts
10
Total ratings
50.00%
Success rate
-13.32%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 10.78 | 85.53% | 3 | Mar 18, 2025 | |
VRNA Verona Pharma | Initiates Coverage On: Buy | 68 | 53.75 | 26.51% | 1 | Jan 10, 2025 | |
RVPH Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 0.52 | 1246.15% | 1 | Jan 10, 2025 | |
CING Cingulate | Initiates Coverage On: Buy | 12 | 3.85 | 211.69% | 1 | Jan 10, 2025 | |
GANX Gain Therapeutics | Maintains: Buy | 7 7 | 1.62 | 332.1% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 7.85 | 269.43% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.41 | 609.22% | 1 | Dec 5, 2024 |